Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
Following which, share price of Wockhardt jumped to a high of Rs 185, and is now up 1.5% at Rs 183. The counter has seen trades of around 36,600 shares so far on the BSE.
Meanwhile, Sun Pharma is trading flat at Rs 1,440. Around 5,880 shares have changed hands at the counter on the BSE.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
